CORONA Remedies Reports Q2 FY27 Consolidated Financial Results
Corona Remedies Ltd 路 Financial Result 路 31 Oct 2026, 12:12 am
CORONA Remedies Reports Q2 FY27 Consolidated Financial Results CORONA Remedies reported a 22.16% YoY increase in consolidated revenue from operations to Rs 441.17 crore for the quarter ended 30th Sep'26, compared to Rs 361.13 crore in the corresponding period last year. Consolidated net profit rose 15.27% YoY to Rs 60.31 crore from Rs 52.32 crore, delivering a basic and diluted EPS of Rs 9.86 versus Rs 8.55. For H1 ended 30th Sep'26, consolidated revenue grew 22.03% YoY to Rs 863.60 crore, while net profit advanced 22.23% YoY to Rs 120.42 crore.
Original exchange filing (PDF)
More announcements from Corona Remedies Ltd
- Intimation of Participation in Analyst / Investor Conference 路 16 Nov 2026
- Intimation of Participation in Analyst / Investor Conference 路 07 Nov 2026
- Transcript of Earnings Call with Analyst / Investor on Unaudited Financial Results for the second quarter and half year ended September 30, 2026 路 05 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 路 04 Nov 2026
- Audio Recording of Q2H1FY27 Earnings Conference Call with Analysts / Investors 路 02 Nov 2026
- Intimation for Analyst / Investor Meet 路 31 Oct 2026
- Analyst / Investor Presentation 路 31 Oct 2026
- Press Release on Financial Results for second quarter and half year ended on September 30, 2026 路 31 Oct 2026
